Earl, H M, Hiller, L, Vallier, A-L, Loi, S, McAdam, K, Hughes-Davies, L, Harnett, A N, Ah-See, M-L, Simcock, R, Rea, D, Raj, S, Woodings, P, Harries, M, Howe, D, Raynes, K, Higgins, H B, Wilcox, M, Plummer, C, Mansi, J, Gounaris, I, Mahler-Araujo, B, Provenzano, E, Chhabra, A, Abraham, J E, Caldas, C, Hall, P S, McCabe, C, Hulme, C, Miles, D, M Wardley, A & Cameron, D A & Dunn, J A 2019, ' 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial ', The Lancet, vol. 393, no. 10191, pp. 2599-2612 . https://doi.org/10.1016/S0140-6736(19)30650-6 Lancet (London, England)
Kirmeier, E, Eriksson, L I, Lewald, H, Jonsson Fagerlund, M, Hoeft, A, Hollmann, M, Meistelman, C, Hunter, J M, Ulm, K, Blobner, M & POPULAR Contributors 2019, ' Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR) : a multicentre, prospective observational study ', The Lancet Respiratory Medicine, vol. 7, no. 2, pp. 129-140 . https://doi.org/10.1016/S2213-2600(18)30294-7 lancet. Respiratory medicine, 7(2), 129-140. Elsevier Limited The Lancet Respiratory Medicine, 7(2), 129-140. Elsevier Limited LANCET RESPIRATORY MEDICINE r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname